OSL oncosil medical ltd

Ann: OncoSil HCC Announcement, page-2

  1. 1,858 Posts.
    I'm confused. Is the CE Mark application for pancreatic cancer submitted or not? In this ann it says,

    "..OncoSil Medical plans to file for CE Mark in both pancreatic and liver cancer indications in H2, 2015..."

    But the last investor update said of pancreatic indication,

    "...CE Mark approval by end Q3 2015.."

    Have they filed for pancreatic or not??
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.16
Change
-0.010(0.86%)
Mkt cap ! $21.74M
Open High Low Value Volume
$1.17 $1.17 $1.14 $80.47K 69.48K

Buyers (Bids)

No. Vol. Price($)
1 2150 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 7380 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.